Subclinical atherosclerosis (SA) in the carotid, femoral, and coronary territories is a powerful predictor of cardiovascular (CV) events. Whether it is sufficient to assess SA in a single vascular territory in early-stage disease is uncertain. We aimed to determine the prevalence and concordance of SA in these vascular beds in asymptomatic patients without known CV disease.
Methods
We enrolled patients aged 35 to 75 years who were asymptomatic, without known CV disease, and had undergone carotid and femoral Doppler ultrasonography and calcium scoring. Those receiving statins were excluded. SA was defined as the presence of plaques in the carotid and/or femoral arteries or the presence of calcium in the coronary arteries (Agatston score >0).
Results
A total of 212 patients were identified with a mean age of 53 ± 7 years, of which 60% (128 patients) were men. The prevalence of SA was 62%. The distribution of SA between the three territories was similar, involving the carotid territory in 38% of cases, the femoral in 31%, and the coronaries in 37%. The concordance between the different vascular territories was weak, with a k index of 0.21 between the coronary and carotid territories, 0.27 between the coronary and femoral territories, and 0.34 between the carotid and femoral territories.
Conclusions
The prevalence of SA in asymptomatic patients without known CV disease is high. The concordance in the presence of SA between the three vascular territories is weak. Therefore, all three vascular beds need to be investigated.
ShahPK.Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we?J Am Coll Cardiol2010;
56: 98–105.
2.
GoffDCJrLloyd-JonesDMBennettG, et al.
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol2014;
63: 2935–2959.
3.
D'AgostinoRBSrVasanRSPencinaMJ, et al.
General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation2008;
117: 743–753.
4.
RidkerPMBuringJERifaiN, et al.
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA2007;
297: 611–619.
5.
MarrugatJSubiranaICominE, et al.
Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study. J Epidemiol Community Health2007;
61: 40–47.
6.
WareJH.The limitations of risk factors as prognostic tools. N Engl J Med2006;
355: 2615–2617.
7.
NasirKMichosEDBlumenthalRS, et al.
Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. J Am Coll Cardiol2005;
46: 1931–1936.
8.
GibbonsRJJonesDWGardnerTJ, et al.
The American Heart Association’s 2008 statement of principles for healthcare reform. Circulation2008;
118: 2209–2218.
9.
LauerMS.Primary prevention of atherosclerotic cardiovascular disease: the high public burden of low individual risk. JAMA2007;
297: 1376–1378.
10.
BelcaroGNicolaidesANRamaswamiG, et al.
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)). Atherosclerosis2001;
156: 379–387.
11.
DetranoRGuerciADCarrJJ, et al.
Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med2008;
358: 1336–1345.
12.
BaberUMehranRSartoriS, et al.
Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J Am Coll Cardiol2015;
65: 1065–1074.
13.
MartinSSBlahaMJBlanksteinR, et al.
Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Circulation2014;
129: 77–86.
14.
GibsonAOBlahaMJArnanMK, et al.
Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study. JACC Cardiovasc Imaging2014;
7: 1108–1115.
15.
ZavodniAEWassermanBAMcClellandRL, et al.
Carotid artery plaque morphology and composition in relation to incident cardiovascular events: the Multi-Ethnic Study of Atherosclerosis (MESA). Radiology2014;
271: 381–389.
16.
GrundySMStoneNJBaileyAL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol2019;
73: 3168–3209.
17.
SteinJHKorcarzCEHurstRT, et al.
Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr2008;
21: 93–111; quiz 89–90.
18.
NasirKRubinJBlahaMJ, et al.
Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals. Circ Cardiovasc Imaging2012;
5: 467–473.
19.
AgatstonASJanowitzWRHildnerFJ, et al.
Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol1990;
15: 827–832.
20.
StoneNJRobinsonJGLichtensteinAH, et al.
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation2014;
129: S1–S45.
21.
Fernandez-FrieraLPenalvoJLFernandez-OrtizA, et al.
Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (Progression of Early Subclinical Atherosclerosis) study. Circulation2015;
131: 2104–2113.
22.
LaclaustraMCasasnovasJAFernandez-OrtizA, et al.
Femoral and carotid subclinical atherosclerosis association with risk factors and coronary calcium: the AWHS study. J Am Coll Cardiol2016;
67: 1263–1274.
23.
van der MeerIMBotsMLHofmanA, et al.
Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam study. Circulation2004;
109: 1089–1094.
24.
PostleyJEPerezAWongND, et al.
Prevalence and distribution of sub-clinical atherosclerosis by screening vascular ultrasound in low and intermediate risk adults: the New York physicians study. J Am Soc Echocardiogr2009;
22: 1145–1151.
25.
PaulTKChenWSrinivasanSR, et al.
Contrast of the impact of multiple cardiovascular risk factors on the femoral and carotid intima-media thickness in asymptomatic young adults: the Bogalusa Heart Study. Atherosclerosis2011;
216: 359–364.
26.
RookeTWHirschATMisraS, et al.
ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol2011;
58: 2020–2045.
27.
KannelWBMcGeeDL.Update on some epidemiologic features of intermittent claudication: the Framingham study. J Am Geriatr Soc1985;
33: 13–18.
28.
PriceJFMowbrayPILeeAJ, et al.
Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J1999;
20: 344–353.
29.
SmithGDShipleyMJRoseG.Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation1990;
82: 1925–1931.
30.
Lloyd-JonesDM.Coronary artery calcium scoring: are we there yet?J Am Coll Cardiol2015;
66: 1654–1656.
31.
PenderALloyd-JonesDMStoneNJ, et al.
Refining statin prescribing in lower-risk individuals: informing risk/benefit decisions. J Am Coll Cardiol2016;
68: 1690–1697.
32.
ShareghiSAhmadiNYoungE, et al.
Prognostic significance of zero coronary calcium scores on cardiac computed tomography. J Cardiovasc Comput Tomogr2007;
1: 155–159.
33.
MiedemaMDDuprezDAMisialekJR, et al.
Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis. Circ Cardiovasc Qual Outcomes2014;
7: 453–460.
34.
BlahaMJBudoffMJDeFilippisAP, et al.
Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet2011;
378: 684–692.
35.
GrundySMCleemanJIMerzCN, et al.
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation2004;
110: 227–239.
36.
FinnAVKolodgieFDVirmaniR.Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arterioscler Thromb Vasc Biol2010;
30: 177–181.
37.
CuspidiCLonatiLSampieriL, et al.
Left ventricular concentric remodelling and carotid structural changes in essential hypertension. J Hypertens1996;
14: 1441–1446.
38.
InabaYChenJABergmannSR.Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis2012;
220: 128–133.
39.
JohnsenSHMathiesenEBJoakimsenO, et al.
Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromso Study. Stroke2007;
38: 2873–2880.
YerlyPRodondiNViswanathanB, et al.
Association between conventional risk factors and different ultrasound-based markers of atherosclerosis at carotid and femoral levels in a middle-aged population. Int J Cardiovasc Imaging2013;
29: 589–599.
42.
BrinkertMRodriguesPRubensM, et al.
An unusual case of false-positive coronary artery calcium score. Oxf Med Case Reports2016;
2016: 71–72.
43.
WallisAManghatNHamiltonM.The role of coronary CT in the assessment and diagnosis of patients with chest pain. Clin Med (Lond)2012;
12: 222–229.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
